Differences in the actions of the M3-antagonist tolterodine and the beta 3 adrenoceptor agonist mirabegron on non-voiding activity in rats with partial outflow obstruction

Gillespie J1, Guilloteau V2, Korstanje C3, Lluel P2, Palea S2

Abstract Category

Bladder Outlet Obstruction (BOO)

Abstract 202
Male LUTS, Clinical and Basic Science
Scientific Podium Session 21
Friday 27th August 2010
09:30 - 09:45
Hall F
1. Newcastle University, Uro-physiology Research group, The Dental and Medical School, Newcastle upon Tyne, NE2 4HH England, 2. UROsphere, Faculty of Pharmaceutical Sciences, 35 Chemin des Maraîchers, 31062 Toulouse Cedex 09, France, 3. Astellas Pharma Europe B.V. Elisabethhof 1 2553 EW Leiderdorp The Netherlands
Presenter
J

James Gillespie
Links

Abstract

23/04/2024 23:41:23